<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Acknowledgements</title>
 <p>The Montreal PHI cohort includes Mario Legault, coordinator and all participating physicians from Clinique médicale L’Actuel, Clinique médicale Quartier Latin, Centre hospitalier Université de Montréal, Clinique Roger Leblanc/Opus and Centre hospitalier Université McGill, including Jean-Guy Baril, Louise Charest, Marc-André Charron, Pierre Côté, Alexandra de Pokomandy, Serge Dufresne, Claude Fortin, Jason Friedman, Norbert Gilmore, Emmanuelle Huchet, Marina Klein, Louise Labreque, Richard Lalonde, Roger Leblanc, Bernard Lessard, Catherine Milne, Marie Munoz, Martin Potter, Danielle Rouleau, Jean-Pierre Routy, Jason Szabo, Réjean Thomas, Cecile Tremblay, Benoît Trottier and Sylvie Vézina. We thank all the patient participants.</p>
 <sec>
  <title>Funding</title>
  <p>This project was supported by the Canadian Institutes for Health Research (CIHR), Fonds de Recherche du Québec (FRQ) Réseau SIDA and FRQ/Research Foundation Flanders (FWO) bilateral programme (202685). M. A. W. received a Large-Scale applied research contract in genomics and personalized healthcare from Genome Canada (HIV142). M. E. Q.-M. was partially supported by the Case Western Reserve University (CWRU)/University Hospitals (UH) Center for AIDS Research (P30 AI036219) and by funding from University Hospitals Cleveland Medical Center (UHCMC) for the University Hospitals Translational Laboratory (UHTL).</p>
  <p> All funders of research played no decision-making role in the design, execution, analysis or reporting of the research.</p>
 </sec>
 <sec>
  <title>Transparency declarations</title>
  <p>B. G. B. has received fees for speaking from Gilead Sciences. M. A. W. has received funds from Gilead Sciences and ViiV Healthcare for speaking and attending symposiums. All other authors: none to declare.</p>
  <p>All authors have read and approved the text.</p>
 </sec>
</ack>
